Brain Imaging and Pain in Irritable Bowel Syndrome

This study has been completed.

First Received: July 31, 2003 Last Updated: August 4, 2008 History of Changes

Sponsor:	National Center for Complementary and Alternative Medicine (NCCAM)
Collaborator:	National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00065754

Purpose

This study examines the mechanisms, including brain imaging of placebo analgesia

Condition	Intervention
Irritable Bowel Syndrome	Drug: placebo

Study Type:	Interventional
Study Design:	Randomized, Double-Blind, Factorial Assignment
Official Title:	Brain Imaging and Pain: Analysis of Placebo Analgesia

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	50
Study Start Date:	September 2003
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion criteria:

Exclusion criteria:

Chronic pain condition other than Irritable Bowel Syndrome
Medical condition that would contraindicate use of lidocaine
Clinical criteria for fibromyalgia
Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
Seropositive HIV
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065754

Locations

United States, Florida
University of Florida
Gainesville, Florida, United States, 32610

Sponsors and Collaborators

Investigators

Principal Investigator:

Michael E Robinson, PhD

University of Florida

More Information

No publications provided

Study ID Numbers:	R01 AT001424-01
Study First Received:	July 31, 2003
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00065754 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Placebo
Analgesia
Pain
Brain mechanism
Expectation

Additional relevant MeSH terms:

Pathologic Processes
Disease
Digestive System Diseases
Gastrointestinal Diseases
Syndrome

Colonic Diseases
Irritable Bowel Syndrome
Intestinal Diseases
Colonic Diseases, Functional

ClinicalTrials.gov processed this record on November 27, 2009